Brokerages Set Agilon Health, Inc. (NYSE:AGL) PT at $2.71

Agilon Health, Inc. (NYSE:AGL) has been given an average rating of “Hold” by the eighteen brokerages that are presently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating on the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $2.7083.

A number of equities analysts have commented on the company. BTIG Research reissued a “neutral” rating on shares of Agilon Health in a research note on Friday, December 12th. Barclays cut their price target on Agilon Health from $1.50 to $1.00 and set an “underweight” rating for the company in a report on Thursday, November 6th. Royal Bank Of Canada raised shares of Agilon Health from a “hold” rating to a “moderate buy” rating in a report on Wednesday, December 3rd. Weiss Ratings restated a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, October 8th. Finally, Wells Fargo & Company reduced their target price on shares of Agilon Health from $1.50 to $1.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 5th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of AGL. American Century Companies Inc. acquired a new stake in shares of Agilon Health in the 1st quarter valued at $594,000. MetLife Investment Management LLC boosted its holdings in Agilon Health by 6.5% in the first quarter. MetLife Investment Management LLC now owns 185,870 shares of the company’s stock valued at $805,000 after acquiring an additional 11,319 shares during the last quarter. Amundi boosted its holdings in Agilon Health by 49.2% in the first quarter. Amundi now owns 1,484,709 shares of the company’s stock valued at $5,939,000 after acquiring an additional 489,414 shares during the last quarter. AQR Capital Management LLC increased its position in Agilon Health by 243.3% in the first quarter. AQR Capital Management LLC now owns 501,440 shares of the company’s stock worth $2,171,000 after purchasing an additional 355,365 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Agilon Health by 3.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock worth $927,000 after purchasing an additional 7,209 shares during the last quarter.

Agilon Health News Summary

Here are the key news stories impacting Agilon Health this week:

• Neutral Sentiment: Several firms opened investigations and urged investors who lost money to contact counsel — these are information/solicitation notices that often precede formal filings and can prompt volatility. agilon health, inc. (AGL) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith
• Neutral Sentiment: Additional investigation/notice from Faruqi & Faruqi advising affected investors of potential claims and an upcoming deadline — procedural development investors should track but does not itself quantify damages. UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health
• Negative Sentiment: Multiple law firms have filed or announced securities class actions alleging misstatements/omissions for purchases during Feb 26, 2025–Aug 4, 2025; lead‑plaintiff motions are due (many notices cite a March 2, 2026 deadline). This raises potential liability, legal costs, and distraction for management. See filings/announcements from Portnoy, Robbins, Gainey McKenna & Egleston, Rosen, Gross and others. Portnoy Law Firm Announces Class Action on Behalf of agilon health, inc. Investors Robbins LLP Class Action Notice Gainey McKenna & Egleston Announcement
• Negative Sentiment: Additional firm notices (Gross Law Firm, Bernstein Liebhard, Wolf Haldenstein, Rosen Law Firm) amplify the narrative that AGL faces coordinated shareholder litigation — multiple filings can increase settlement leverage for plaintiffs and raise defense costs. The Gross Law Firm Notifies agilon health, inc. Investors Bernstein Liebhard Investor Alert Wolf Haldenstein Notice

Agilon Health Stock Up 15.3%

NYSE:AGL opened at $0.90 on Friday. The firm has a market cap of $373.12 million, a PE ratio of -1.20 and a beta of 0.05. Agilon Health has a 12 month low of $0.51 and a 12 month high of $6.08. The company’s 50-day moving average price is $0.68 and its two-hundred day moving average price is $1.18.

Agilon Health (NYSE:AGL) last posted its earnings results on Tuesday, November 4th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.09). The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.43 billion. Agilon Health had a negative net margin of 5.24% and a negative return on equity of 75.92%. On average, research analysts expect that Agilon Health will post -0.59 EPS for the current fiscal year.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.